Hyperion DeFi (HYPD) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
5 May, 2026Executive summary
The annual meeting will be held virtually on June 30, 2026, with stockholders able to attend and vote online after registering in advance.
Stockholders of record as of May 4, 2026, are entitled to vote on five key proposals, including director elections, auditor ratification, executive compensation, a charter amendment, and potential adjournment.
Proxy materials, including the annual report and proxy statement, are available online, and voting can be conducted via internet, phone, or mail.
Voting matters and shareholder proposals
Proposal 1: Election of five directors for one-year terms expiring in 2027.
Proposal 2: Ratification of CBIZ CPAs P.C. as independent auditor for fiscal year ending December 31, 2026.
Proposal 3: Advisory vote on executive compensation (say-on-pay).
Proposal 4: Amendment to the charter to allow stockholder action by written consent.
Proposal 5: Adjournment of the meeting if necessary to solicit additional proxies for Proposal 4.
No shareholder proposals were received for this meeting.
Board of directors and corporate governance
The board consists of five members, with four deemed independent under Nasdaq rules.
Committees include Audit, Compensation, and Nominating and Corporate Governance, each with written charters.
The board does not have a chairperson or lead independent director; presiding director is designated as needed.
Director nominations can be made by stockholders following specific procedures.
Board and committee meetings were well attended in 2025, with all directors meeting attendance requirements.
Latest events from Hyperion DeFi
- Virtual meeting to vote on directors, auditor, compensation, and written consent amendment.HYPD
Proxy filing5 May 2026 - Five key proposals, governance updates, and compensation details set for the 2026 annual meeting.HYPD
Proxy filing17 Apr 2026 - Q4 adjusted gross profit jumped 87% QoQ, with 2026 guidance targeting 4x FY 2025 results.HYPD
Q4 202529 Mar 2026 - Q2 net loss rose to $11.1M as cash fell and late-stage ophthalmic programs advanced.HYPD
Q2 20241 Feb 2026 - Q3 net loss was $7.9M as new launches advanced but liquidity concerns remain.HYPD
Q3 202414 Jan 2026 - All recent capital is used to build a HYPE token reserve, exposing the business to crypto volatility.HYPD
Registration Filing16 Dec 2025 - Shelf registration allows up to $100M in offerings, including $25M at-the-market sales via Leerink Partners.HYPD
Registration Filing16 Dec 2025 - Up to 6.37 million shares registered for resale as company pursues strategic options and faces liquidity risks.HYPD
Registration Filing16 Dec 2025 - Building a HYPE token treasury and advancing ophthalmic tech, with high exposure to crypto volatility.HYPD
Registration Filing16 Dec 2025